Search Videos and More
Peyronie’s Disease Presentation and Assessment
Michael J. Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses history, presentation and assessment of Peyronie’s Disease.Transgender Health & Gender Affirming Surgery
Laura Douglass, MD (she/her), Fox Chase-Temple Urologic Institute Provider, discusses transgender health and gender affirming surgery. She discusses the importance of transgender and nonbinary health and how to provide gender affirming care. She also provides an overview of Gender Affirming Surgery.Pulmonary Hypertension: An update on diagnosis, treatment and risk assessment
Pulmonary hypertension encompasses a broad scope of disease states. This program will focus on pulmonary arterial hypertension (PAH) which begins as a vasculopathy within the small pulmonary arteries.Buccal Mucosa Graft Ureteroplasty: Technical Pointers
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, provides an overview of buccal mucosa graft ureteroplasty procedure and pointers for providers looking to learn how to perfom.Pelvic Lymphoceles: Tips & Tricks to Avoid and Manage Them
Complications post surgery can include the development of pelvic lymphoceles which patients may present infection or external leaks. Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses how to avoid and manage lymphoceles post robotic surgery.CTEPH Diagnosis and Management in 2022: Grand Rounds with Dr. Anjali Vaidya
Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple Health shares advanced diagnosis and managment for chronic thromboembolic pulmonary hypertension.Robotic Assisted Laparoscopic Left Ileal Ureter Interposition for Long Segment Ureteral Stricture
Daniel Eun, MD, Michael Metro, MD, and other Fox Chase-Temple Urologic Institute Providers present a 53-year-old patient diagnosed with bilateral ureteral strictures from tuberculosis who undergoes a bilateral ureteral reconstruction.Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease
Non-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.Optimal Pharmaceuticals to Support Blood Pressure Management
Paul H. Pronovost, MD, FACP, FASN; Interim Chief, Section of Nephrology, Hypertension and Kidney Transplantation at the Lewis Katz School of Medicine at Temple University discusses challenges in the medical management of hypertension.Hard-to-control Hypertension and When to Consider a Referral to Advanced Program for Complex Hypertension
Ajaykumar D. Rao, MD, MMSc, FACP, discusses the complexity of patients with resistant hypertension and secondary hypertension, and when patients benefit from a referral to clinical hypertension experts.Strategies for Patient Adherence to Blood Pressure Management Therapies
Daniel Edmundowicz, MS, MD, FACP, FACC, Chief, Cardiology, Temple University Hospital discusses the challenges of maintaining long-term adherence of preventative medications for hypertension.Diaphragm Dysfunction
While respiratory muscle dysfunction is well-documented, it’s often an underdiagnosed cause of dyspnea, and requires a multidisciplinary approach. Sources range from focal diaphragm dysfunction to systemic neuromuscular disease, often with overlooked symptoms and delayed diagnosis. This CME activity is divided into three sections, with a focus on general approach and diagnostic modalities for patients with suspected respiratory muscle impairment, surgical interventions for unilateral diaphragm dysfunction, and evaluation and treatment of systemic neuromuscular diseases.